Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 905-287-4 | CAS number: 1638758-52-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- No data are available for the target substance. Studies of genotoxicity in vitro with the individual (o-, m- and p-) cresol isomers report negative results in Ames tests and mammalian cell mutation assays and positive results in studies of chromosomal aberration in vitro. Studies of genotoxicity in vivo report negative results. Studies of genotoxicity in vitro with xylenol (mixed isomers) report negative results in Ames tests and mammalian cell mutation assays and positive results in studies of chromosomal aberration in vitro. Studies of genotoxicity in vivo report negative results for 3,5-, 2,4- and 2,6-xylenol. Based on the consistent response seen for the source substances, it can be concluded that the target substance is also not genotoxic.
Data source
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Reaction mass of 2,4-xylenol and 2,5-xylenol
- EC Number:
- 905-287-4
- Cas Number:
- 1638758-52-7
- Molecular formula:
- (CH3)2C6H3OH
- IUPAC Name:
- Reaction mass of 2,4-xylenol and 2,5-xylenol
- Test material form:
- solid: bulk
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Duration of treatment / exposure:
- Single oral administration
- Frequency of treatment:
- Single oral administration
- Post exposure period:
- 24 and 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:375, 750 and 1500 mg/kg (24 hr) and 1500 mg/kg (48 hr)Basis:no data
- No. of animals per sex per dose:
- 5 animals/dose/sex
- Control animals:
- yes, concurrent vehicle
Examinations
- Tissues and cell types examined:
- Polychromatic erthyrocyte (PCE) examined for the presence of micornulcueiPCE and noromchromatic erthyrocytes (NCE) counted as a measure of toxiciy
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Clincial signs of toxicity, with mortality
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Table 1: Male and female combined data - 24hr time point
Dose (mg/kg) |
PCE |
NCE |
Total |
%PCE |
MN PCE |
0 |
20000 |
7942 |
27944 |
39.7 |
1.5 |
75 |
20000 |
7225 |
27228 |
36.1 |
1.0 |
750 |
20000 |
6986 |
26991 |
34.9 |
0.7 |
1500 |
20000 |
8175 |
28182 |
40.2 |
1.0 |
CPA 20 |
10000 |
4610 |
14612 |
46.1 |
11.6** |
VIN 0.15 |
10000 |
4721 |
14721 |
47.2 |
60.9** |
CPA - cyclophosphamide
VIN - Vincristine
** p<0.01
Table 2: Male and female combined data - 48hr time point
Dose (mg/kg) |
PCE |
NCE |
Total |
%PCE |
MN PCE |
0 |
20000 |
7968 |
27968 |
39.8 |
0.8 |
1500 |
16000 |
9474 |
25484 |
59.2 |
0.8 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negativeIt is concluded that 3,5 xylenol did not induce micronuclei in the polychromatic erthrocytes of the bone marrow following sampling at 24 and 48 hours post dosing of both male and female rats when tested at a dose of 1500 mg/kg (deemed a maximum tolerated dose) under the conditions of the assay described.
- Executive summary:
In a bone marrow micronucleus assay using NMRI mice, a single oral gavage of 3,5-xylenol was administered to groups of male and female animals, employing a dose volume of 10 mL/kg. Doses were selected from a pilot toxicity study doses of 1500 and 1750 mg/kg/bw were administered. Mortality was observed in at 1750mg/kg and evident signs of toxicity were observed at 1500mg/kg. The MTD was therefore deemed to be 1500 mg/kg.
Negative control groups were treated with vehicle only (olive oil) and positive control groups were treated with the clastogen, cyclophosphamide (CPA, 20 mg/kg bw) or the aneugen, vincristine (0.15 mg/kg). Mouse bone marrow was sampled at 24 and 48 hours after dosing for the vehicle and 3,5 xylenol dosed groups. A single sampling time of 24 hours after dosing was used for both positive control groups. Slides of bone marrow cells were prepared from five animals/sex/time point for each group and scored for the occurrence of micronucleated polychromatic erythrocytes (MN PCE) and PCE/total erythrocyte ratios.
Deaths (1 male and 1 female) at 1500mg/kg, 48 hr sample point were observed. Clinical signs of toxicity included irregular breathing (375mg/kg). squatting posture (750mg/kg) and piloerection and squatting (1500mg/kg). There were no marked decreases in mean PCE/total erythrocyte ratio observed for any of the 3,5 xylenol treated groups compared to the vehicle control group for either time point.
Analysis of the mean MN PCE group data indicated that there was no statistically significant increases MN PCE frequency compared to concurrent control values for either sex. Indiviudaul animal and group mean MN PCE frequencies were consistent with both the concurrent vehicle control values and the historical control. Positive control treatment induced the appropriate response.
Formulation analysis confirmed the suitability of the doses prepared.
It is concluded that 3,5 xylenol did not induce micronuclei in the polychromatic erthrocytes of the bone marrow following sampling at 24 and 48 hours post dosing of both male and female rats when tested at a dose of 1500 mg/kg (deemed a maximum tolerated dose) under the conditions of the assay described.
The above results are suitable to be used for read across for Reaction mass of 2,4-xylenol and 2,5-xylenol, due to the category being based on structural similarity and comparable physicochemical properties, leading to similar (eco)toxicological properties.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.